Thousand Oaks, CA, United States of America

Susana C Neira

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2009 - 2011)
  • Naperville, IL (US) (2010 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Susana C Neira: Innovator in Pharmaceutical Chemistry

Introduction

Susana C Neira is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work primarily focuses on developing innovative compounds that address various medical conditions.

Latest Patents

Among his latest patents, Neira has developed Azaquinolones that inhibit prolyl hydroxylase. These compounds are useful inhibitors of HIF prolyl hydroxylases, showcasing a novel approach to treating related diseases. Another notable patent involves S1P receptor modulating compounds, which are amides that act as SIP receptor modulating agents. These compounds have potential applications in treating autoimmune disorders and other conditions, including systemic lupus erythematosus and inflammatory bowel diseases.

Career Highlights

Throughout his career, Neira has worked with leading companies in the pharmaceutical industry, including Amgen Inc. and Epix Pharmaceuticals, Inc. His expertise in drug development has positioned him as a key figure in advancing therapeutic solutions.

Collaborations

Neira has collaborated with notable professionals in his field, including Roland W Burli and Jennifer Rebecca Allen. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Susana C Neira's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…